Viewing Study NCT01214720


Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2025-12-26 @ 3:02 AM
Study NCT ID: NCT01214720
Status: COMPLETED
Last Update Posted: 2014-08-13
First Post: 2010-10-04
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic Cancer
Sponsor: Hoffmann-La Roche
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-07
Start Date Type: None
Primary Completion Date: 2008-10
Primary Completion Date Type: ACTUAL
Completion Date: 2008-10
Completion Date Type: ACTUAL
First Submit Date: 2010-10-04
First Submit QC Date: None
Study First Post Date: 2010-10-05
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2014-07-23
Results First Submit QC Date: None
Results First Post Date: 2014-08-13
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-07-23
Last Update Post Date: 2014-08-13
Last Update Post Date Type: ESTIMATED